Efficacy of Hemodynamic-Guided Heart Failure Management in Patients Enrolled With Elevated Natriuretic Peptide Levels but Without a Recent HF Hospitalization: An Analysis of the GUIDE-HF Trial
We Recommend
Disclosures
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:
- Grant Support/Research Contract (Institutional) - Abbott Vascular; Alnylam; Bayer AG; AstraZenca; Novartis
- Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Abbott Vascular; Alnylam; Bayer AG; AstraZenca; Novartis; Amgen; Biofourmis; Boston Scientific Corporation; Cytokinetics; DalCor Pharma; Merck/Schering Plough; Lexicon; Lupin Pharma; Relypsa; Regeneron; Verily